1. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175) : a systematic review and economic evaluation /: a systematic review and economic evaluation. (June 2015) Authors: Greenhalgh, J (Janette) Other Names: NIHR Journals Library, publisher.; National Institute for Health Research (Great Britain) Record Type: Book Extent: 1 online resource (xxiv, 133 pages), illustrations (colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer : a systematic review and cost-effectiveness analysis /: a systematic review and cost-effectiveness analysis. (May 2014) Authors: Westwood, M (Marie) Other Names: NIHR Journals Library, publisher.; National Institute for Health Research (Great Britain) Record Type: Book Extent: 1 online resource (xxi, 165 pages), illustrations (black and white, and colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer : a systematic review and economic evaluation /: a systematic review and economic evaluation. (May 2015) Authors: Brown, T (Tamara) Record Type: Book Extent: 1 online resource (2 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overcoming resistance to EGFR inhibitors in EGFR mutant NSCLC. (2022) Editors: Faber, Anthony Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗